Etomoxir

Uses your system voice; voice and rate in settings.

Snapshot

≈ 3 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Etomoxir, or rac-Ethyl 2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate, in the form of the dextrorotatory (R)-(+)- enantiomer, is an irreversible inhibitor of carnitine palmitoyltransferase-1 (CPT-1; EC 2.3.1.21) on the inner face of the outer mitochondrial membrane. The biologically active inhibitor – (R)-(+)-etomoxir-Coenzyme A ester – is formed through an intracellular process. The mean concentration for the inhibition of the CPT-1 in the liver, heart, and muscle mitochondria of rats is 20 micromolar/kilogram rac-Etomoxir.

How it works

(+)-Etomoxir is a colourless solid with a melting point of . The sodium salt of (+)-Etomoxir is water-soluble. The (S)-(-)-enantiomer of Etomoxir does not block CPT-1. Etomoxir's mechanism prevents the formation of acyl carnitines, a step that is necessary for the transport of fatty acyl chains from the cytosol into the intermembrane space of the mitochondria. This step is essential to the production of ATP from fatty acid oxidation. Etomoxir has also been identified as a direct agonist of PPARα, causing cell cycle arrest in cancer cells.

Impact

At higher concentrations of the drug, off-target effects have been demonstrated on Coenzyme-A (CoA) metabolism and on Complex I of the electron transport chain. The influence of Etomoxir on food uptake is a matter of discussion, as contradictory findings have been reported.

Etomoxir, or rac-Ethyl 2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate, in the form of the dextrorotatory (R)-(+)- enantiomer, is an irreversible inhibitor of carnitine palmitoyltransferase-1 (CPT-1; EC 2.3.1.21) on the inner face of the outer mitochondrial membrane. The biologically active inhibitor – (R)-(+)-etomoxir-Coenzyme A ester – is formed through an intracellular process. The mean concentration for the inhibition of the CPT-1 in the liver, heart, and muscle mitochondria of rats is 20 micromolar/kilogram rac-Etomoxir.

(+)-Etomoxir is a colourless solid with a melting point of . The sodium salt of (+)-Etomoxir is water-soluble. The (S)-(-)-enantiomer of Etomoxir does not block CPT-1. Etomoxir's mechanism prevents the formation of acyl carnitines, a step that is necessary for the transport of fatty acyl chains from the cytosol into the intermembrane space of the mitochondria. This step is essential to the production of ATP from fatty acid oxidation. Etomoxir has also been identified as a direct agonist of PPARα, causing cell cycle arrest in cancer cells.

At higher concentrations of the drug, off-target effects have been demonstrated on Coenzyme-A (CoA) metabolism and on Complex I of the electron transport chain. The influence of Etomoxir on food uptake is a matter of discussion, as contradictory findings have been reported.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1375918500 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

6 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.